Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
OKYO Pharma Ltd - London-headquartered biotechnology company - Executive Chair Gabriele Cerrone buys 5.8 million shares via Panetta Partners Ltd at £0.0625, worth £362,500, on Thursday. Cerrone now has a 39% stake in the company.
Current stock price: 4.70 pence, up 4.4% on Friday in London
12-month change: down 25%
Copyright 2022 Alliance News Limited. All Rights Reserved.